Skip to content
drillr.ai
Sign up

ACRV

Acrivon Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.85
+8.82%
Ask drillr
0
Insider buys (3m)
9
Insider sells (3m)
-$39.8K
Net value (3m)
+17.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 2, 2026Levin Michaela · officer: Chief Business OfficerA-Award130,000$2.09
Sep 2, 2026Levin Michaela · officer: Chief Business OfficerA-Award30,000$0.00
Aug 27, 2026Blume-Jensen Peter · director, officer: President and CEOSale14,036$2.21
Aug 20, 2026Miller Mary · officer: Chief Legal OfficerSale185$2.01
Aug 20, 2026Gamelin Erick · officer: Chief Development OfficerSale400$2.01
Aug 20, 2026Devroe Eric · officer: Chief Operating OfficerSale604$2.01
Aug 20, 2026Blume-Jensen Peter · director, officer: President and CEOSale1,229$2.01
Aug 20, 2026Blume-Jensen Peter · director, officer: President and CEOSale484$2.01
Aug 20, 2026Peterson Katharine · officer: Chief Accounting OfficerSale101$2.01
Aug 6, 2026Levy Adam D. · officer: Chief Financial OfficerSale1,142$1.57
Jul 23, 2026Miller Mary · officer: Chief Legal OfficerSale573$1.76
Jun 22, 2026Palani Santhosh · directorA-Award20,275$1.52
Jun 22, 2026Magovcevic-Liebisch Ivana · directorA-Award20,275$1.52
Jun 22, 2026DiRocco Derek · directorA-Award20,275$1.52
Jun 22, 2026BAUM CHARLES M · directorA-Award20,275$1.52
Jun 22, 2026RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: A-Award20,275$1.52
Jun 22, 2026TOMSICEK MICHAEL JOHN · directorA-Award20,275$1.52
Jun 22, 2026Shacham Sharon · directorA-Award20,275$1.52
May 26, 2026Blume-Jensen Peter · director, officer: President and CEOF-InKind13,729$1.79
May 20, 2026Blume-Jensen Peter · director, officer: President and CEOA-Award180,095$0.00
May 20, 2026Blume-Jensen Peter · director, officer: President and CEOA-Award72,706$0.00
May 20, 2026Devroe Eric · officer: Chief Operating OfficerA-Award72,981$0.00
May 20, 2026Gamelin Erick · officer: Chief Development OfficerA-Award38,584$0.00
May 20, 2026Levy Adam D. · officer: Chief Financial OfficerA-Award46,167$0.00
May 20, 2026Miller Mary · officer: Chief Legal OfficerA-Award49,830$0.00
May 20, 2026Mirza Mansoor Raza · officer: Chief Medical OfficerA-Award38,817$0.00
May 20, 2026Peterson Katharine · officer: Chief Accounting OfficerA-Award14,227$0.00
May 20, 2026BAUM CHARLES M · directorA-Award9,366$0.00
May 20, 2026DiRocco Derek · directorA-Award9,366$0.00
May 20, 2026Magovcevic-Liebisch Ivana · directorA-Award9,366$0.00
Institutional positioning

13F filings over the trailing two quarters

New 16Increased 33Reduced 20Sold out 4
FilerActionSharesFiled
RA CAPITAL MANAGEMENT, L.P.Increased12,229,396Aug 14, 2026
RA CAPITAL MANAGEMENT, L.P.Unchanged8,340,508May 15, 2026
Sands Capital Alternatives, LLCIncreased2,289,271Aug 13, 2026
SANDS CAPITAL VENTURES, LLCUnchanged2,122,605May 8, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased1,165,119Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased952,008Aug 13, 2026
WELLINGTON MANAGEMENT GROUP LLPUnchanged888,130May 15, 2026
WELLINGTON MANAGEMENT GROUP LLPUnchanged888,130Aug 14, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased845,973May 13, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased758,863Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased758,440May 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position722,035May 15, 2026
TWO SIGMA INVESTMENTS, LPIncreased641,498Aug 14, 2026
MARSHALL WACE, LLPIncreased560,436May 15, 2026
MARSHALL WACE, LLPReduced531,856Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026